Increased donor representation with SS erythroblast maturation, as enumerated by ABO antibody staining of bone marrow biopsies
. | Donor early erythroblasts (%) . | Donor late erythroblasts (%) . |
|---|---|---|
| SCD patient 1 | 52 of 97 (54%) | 130 of 156 (83%) |
| SCD patient 2 | 24 of 45 (53%) | 110 of 145 (76%) |
| Non-SCD patient 5 | 19 of 30 (63%) | 73 of 105 (69%) |
| Non-SCD patient 6 | 23 of 67 (34%) | 40 of 121 (33%) |
. | Donor early erythroblasts (%) . | Donor late erythroblasts (%) . |
|---|---|---|
| SCD patient 1 | 52 of 97 (54%) | 130 of 156 (83%) |
| SCD patient 2 | 24 of 45 (53%) | 110 of 145 (76%) |
| Non-SCD patient 5 | 19 of 30 (63%) | 73 of 105 (69%) |
| Non-SCD patient 6 | 23 of 67 (34%) | 40 of 121 (33%) |